AMI患者PCI术后无/慢复流发生与应激血糖及超敏C反应蛋白的关系

Relationship of no or slow reflow of patients with acute myocardial infarction after PCI with the stressing blood sugar or hs-CRP

目的:探讨急性心肌梗死(AMI)患者行急诊经皮冠状动脉介入治疗(PCI)后无/慢复流的发生与应激血糖及超敏C反应蛋白(hs-CRP)的关系。方法:将首次发生且症状出现至就诊时间≤6 h的ST段抬高型心梗(STEMI)患者253例,分成无/慢复流组及对照组,观察两组间应激血糖、hs-CRP及一般资料、手术相关指标之间的差异。结果:26例(10.3%)患者于PCI后出现了无/慢复流,无慢复流组应激血糖、hs-CRP、白细胞数以及罪犯血管开通时间、球囊扩张压力、住院期间病死率均高于对照组(P<0.05或P<0.01)。结论:应激血糖及hs-CRP水平与AMI患者PCI术后无/慢复流的发生有关,并可提示预后不良。

Objective： To study the relationship between the stressing blood sugar or hs-CRP and the occurrence of no or slow reflow in patients with acule myocardial infarction after primary PCI. Methods： We admitted 253 patients with chest pain who had been suspected as STEMI from heart center of our hospital. The time of D-to-B was less than 6 hours. The patients were divided into no or slow reflow group and normal control group according to the results of CAG. Then the differences of general data, the stressing blood sugar, hs-CRP and other surgery-related indicators between the two groups were studied. Results： Twenty-six （ 10.3% ） patients had occurred no or slow reflow after PCI, and the stressing blood sugar,hs-CRP of group with no or slow reflow were significantly increased compared with the normal control group（P 〈0.05 or P 〈 0. 01 ）. Conclusion： The detection of stressing blood sugar and hs-CRP were correlated to the occurrence of no or slow reflow after primary PCI, and can be used to predict the prognosis.